MedTrace Logo

Assessment of the Natural Anticoagulant Profile in Patients With COVID-19

NCT05083104 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-10-19

No results posted yet for this study

Summary

At the beginning of 2020, coronavirus disease 19 (COVID-19) was declared a pandemic of international concern and an unprecedented challenge for country-specific health care systems . Patients infected with COVID-19 develop from mild, self-limiting respiratory tract illness to severe progressive pneumonia associated with multi-organ failure . In particular, COVID-19 has been shown to exert significant effects on the hematopoietic system and hemostasis

Conditions

  • COVID-19 Patients

Interventions

DIAGNOSTIC_TEST

laboratory investigations on coagulation profiles

CBC ,PT ,aPTT ,Protein C .Protein S ,ATIII and vWF

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-11-01
Completion
2022-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05083104 on ClinicalTrials.gov